期刊
NUTRIENTS
卷 14, 期 5, 页码 -出版社
MDPI
DOI: 10.3390/nu14050921
关键词
supplementation; mental health; depression; amino acids
Creatine supplementation has been found to increase creatine content in the brain and shows potential for alleviating symptoms of mild traumatic brain injury and depression. However, its effect on neurodegenerative diseases is limited. Additionally, creatine supplementation may improve cognition and provide neuroprotective effects.
While the vast majority of research involving creatine supplementation has focused on skeletal muscle, there is a small body of accumulating research that has focused on creatine and the brain. Preliminary studies indicate that creatine supplementation (and guanidinoacetic acid; GAA) has the ability to increase brain creatine content in humans. Furthermore, creatine has shown some promise for attenuating symptoms of concussion, mild traumatic brain injury and depression but its effect on neurodegenerative diseases appears to be lacking. The purpose of this narrative review is to summarize the current body of research pertaining to creatine supplementation on total creatine and phophorylcreatine (PCr) content, explore GAA as an alternative or adjunct to creatine supplementation on brain creatine uptake, assess the impact of creatine on cognition with a focus on sleep deprivation, discuss the effects of creatine supplementation on a variety of neurological and mental health conditions, and outline recent advances on creatine supplementation as a neuroprotective supplement following traumatic brain injury or concussion.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据